Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University has been ranked first in the UK for turning academic research into spinout companies, according to a new report published today by data analyst firm Beauhurst.

Nanopore scientist with gridion technology and pipette

The report, sponsored by the Royal Academy of Engineering, has identified 193 spinouts emerging from Oxford University since 2011, ahead of Cambridge University in second place with 137, with Imperial College London and University College London ranked third and fourth, with 106 and 88 spinouts respectively.

Oxford was also found to have the most active cluster for spinouts, with 90 such firms based in the local authority for Oxford alone. Many of these are have been successful in finding solutions to some of the biggest challenges facing the world today. Areas of innovation include sustainable transport, green energy, poverty alleviation, and medical diagnostics.

The report comes after several record-breaking years for innovation in Oxford, tracked by the University’s commercialisation arm, Oxford University Innovation (OUI). Through OUI, the University created 31 new companies during the 2020/21 academic year, bolstered by the University’s support for social ventures.

Read the full story on the University of Oxford website

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.